• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The Epigenome Analysis of the Mechanisms of Chemoresistance and Development new treatment in Rhabdoid Tumor

Research Project

Project/Area Number 25461602
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pediatrics
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

KUWAHARA YASUMICHI  京都府立医科大学, 医学(系)研究科(研究院), 講師 (30590327)

Co-Investigator(Kenkyū-buntansha) HOSOI Hajime  京都府立医科大学, 大学院医学研究科, 教授 (20238744)
IEHARA Tomoko  京都府立医科大学, 大学院医学研究科, 准教授 (20285266)
TSUCHIYA Kunihiko  京都府立医科大学, 大学院医学研究科, 講師 (90381938)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Keywordsラブドイド腫瘍 / SNF5 / クロマチンリモデリング / NOXA / 薬剤感受性 / アポトーシス / 悪性ラブドイド腫瘍 / 薬剤耐性 / Mcl-1
Outline of Final Research Achievements

Malignant rhabdoid tumor (MRT) is a highly aggressive pediatric cancer characterized by inactivation of SNF5, a core subunit of SWI/SNF complexes. Previously, we showed SNF5 contributes to transcriptional activation of NOXA, a pro-apoptotic protein that binds and inhibits the anti-apoptotic protein MCL-1. In this study, we found that NOXA expression was downregulated in both MRT cell lines and in clinical samples and that ectopically expressed NOXA bound MCL-1 and increased the sensitivity of MRT cell lines to doxorubicin (DOX) by promoting apoptosis. We also showed that knockdown of MCL-1 in MRT cell lines induced apoptosis and increased DOX sensitivity in MRT cells. Furthermore, we generate mice xenografts for both MCL-1 knockdown (KD) and control cell lines. We observed that mean tumor volume in the DOX-treated MCL-1 KD group was significantly smaller than that in the control group. Our results suggest that modulation of the NOXA/MCL-1 pathway underlies a chemoresistance in MRT.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • Research Products

    (7 results)

All 2015 2014 2013 Other

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Acknowledgement Compliant: 1 results) Presentation (4 results) (of which Int'l Joint Research: 1 results,  Invited: 1 results)

  • [Journal Article] A NOXA/MCL-1 Imbalance Underlies Chemoresistance of Malignant Rhabdoid Tumor Cells.2015

    • Author(s)
      Ouchi K, Kuwahara Y, Iehara T, Miyachi M, Katsumi Y, Tsuchiya K, Konishi E, Yanagisawa A, Hosoi H.
    • Journal Title

      J Cell Physiol.

      Volume: 9999 Issue: 9 Pages: 1-9

    • DOI

      10.1002/jcp.25293

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.2014

    • Author(s)
      Wei D, Goldfarb D, Song S, Cannon C, Yan F, Sakellariou-Thompson D, Emanuele M, Major MB, Weissman BE, Kuwahara Y.
    • Journal Title

      Mol Cancer Res.

      Volume: 12 Issue: 11 Pages: 1574-1585

    • DOI

      10.1158/1541-7786.mcr-14-0005

    • Related Report
      2014 Research-status Report
    • Peer Reviewed
  • [Journal Article] SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.2013

    • Author(s)
      Kuwahara Y, Wei D, Durand J, Weissman BE.
    • Journal Title

      Mol Cancer Res

      Volume: 11 Issue: 3 Pages: 251-260

    • DOI

      10.1158/1541-7786.mcr-12-0390

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] SMARCB1/INI1の機能解析よりわかったラブドイド腫瘍の病態生理2015

    • Author(s)
      桒原康通
    • Organizer
      第6回小児がん学術セミナー
    • Place of Presentation
      東京
    • Year and Date
      2015-09-19
    • Related Report
      2015 Annual Research Report
    • Invited
  • [Presentation] Loss of NOXA expression by INI1/SNF5 loss impaired sensitivity to chemotherapeutic agents in malignant rhabdoid tumor in vitro and vivo2015

    • Author(s)
      Kazutaka Ouchi, Yasumichi Kuwahara, Tomoko Iehara, Eiichi Konishi, Hajime Hosoi
    • Organizer
      1st International rhabdoid tumor group meeting.
    • Place of Presentation
      Paris, France
    • Year and Date
      2015-04-18 – 2015-04-22
    • Related Report
      2014 Research-status Report
  • [Presentation] Loss of NOXA expression by INI1/SNF5 loss impaired sensitivity to chemotherapeutic agents in malignant rhabdoid tumor in vitro and iv vivo.2015

    • Author(s)
      Ouchi K, Kuwahara Y, Iehara T, Konishi E, Hosoi H.
    • Organizer
      106th American Association for Cancer Research Annual Meeting.
    • Place of Presentation
      Philadelphia, PA,U.S.A.
    • Year and Date
      2015-04-18
    • Related Report
      2015 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Function analysis of NOXA expression in malignant rhabdoid tumor.

    • Author(s)
      Ouchi K, Kuwahara Y、Tsuchiya K, Iehara T, Hosoi H.
    • Organizer
      第55回日本小児血液・がん学会学術集会
    • Place of Presentation
      福岡
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi